High-dose dexamethasone for splenectomy in patients with idiopathic thrombocytopenic purpura

Haemostasis. 1998 Sep-Oct;28(5):256-9. doi: 10.1159/000022440.

Abstract

High-dose intravenous immune globulin (IV IgG) is currently the treatment of choice for patients with idiopathic thrombocytopenic purpura (ITP) who undergo splenectomy; however, this treatment is extremely expensive. We report on 13 ITP patients with severe thrombocytopenia (<20 x 10(9)/l) who were prepared for laparoscopic splenectomy with a 4-day oral course of high-dose (40 mg/day) dexamethasone (DEX). Four patients had an excellent response with platelet counts that increased to above 150 x 10(9)/l. Seven patients had a good response with a platelet count that increased to between 50 and 150 x 10(9)/l (median 121 x 10(9)/l). Two patients were resistant both to DEX and IV IgG. The operation was uneventful in all the patients, including the 2 who had resistant ITP and were operated on while their platelet count was very low (5 x 10(9)/l). Thus, high-dose DEX, which is an easy, effective and inexpensive treatment, is recommended for the preparation of ITP patients prior to splenectomy.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Dexamethasone / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Platelet Count
  • Preoperative Care / methods*
  • Purpura, Thrombocytopenic, Idiopathic / therapy*
  • Splenectomy*

Substances

  • Dexamethasone